Inadequate funding may crimp UK stem cell work; new target for cancer researchers; first genetic map for bipolar disease

Stem Cell Research

Researchers in the UK are sounding the alarm that inadequate funding will crimp stem cell R&D and spur many scientists in the field to work abroad. Report

The oversight board of California's stem cell agency should be reduced to 15 and new members representing the general public interest must be included, says Consumer Watchdog. In addition, the agency's grant review process must be opened to public scrutiny. Release

Cancer Research

Scientists in Belgium say that new therapeutics that target a protein that allows tumor cells to refuel may be an effective new approach to fighting cancer. Report

The neuropeptide, hypocretin-1 (Orexin A), may initiate a key signaling cascade, a series of closely linked biochemical reactions, which maintains tobacco addiction in human smokers and could be a potential target for developing new smoking cessation treatments. Release

Genetics

A new study by researchers suggests that Parkin, the product of the Parkinson's disease-related gene Park2, prompts neuronal survival by clearing the cell of its damaged mitochondria. Release

Neuroscientists at the Indiana University School of Medicine have created the first comprehensive map of genes likely to be involved in bipolar disorder, according to research published online Nov. 21 in the American Journal of Medical Genetics. Release

Suggested Articles

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.

Enhertu produced a 55.6% objective response rate in HER2-positive non-small cell lung cancer patients in a phase 1 trial.